Nevena Ž. Vučen Papić - Infectious Diseases

Author Information

Neven Papić is affiliated with the Department of Viral Hepatitis at the University Hospital for Infectious Diseases in Zagreb, Croatia. Based in Zagreb, Neven's work is central to the field of infectious diseases, with a keen focus on viral hepatitis.

Research Contributions

Neven Papić has made significant contributions to the field of infectious diseases, with particular research interests in the interactions between non-alcoholic fatty liver disease (NAFLD) and various infectious conditions, such as COVID-19, Clostridioides difficile infections, and bacterial infections in liver cirrhosis. Neven's research also extends to studying severe viral diseases, such as West Nile Virus, and exploring the use of extracorporeal membrane oxygenation in treating ARDS in influenza and COVID-19 patients. This body of work reflects a comprehensive approach to understanding the complex relationships between liver disease and infectious diseases.

Aliases

Neven Papić is also known by several aliases, including N Papic, N. Papic, Nevena Ž. Vucen Papić, and Neven Papic. These variations may appear in different publications or databases.

Publication and Citation Metrics

Metric	Value
Citation Count	735
H-index	12
Paper Count	69

Publications:

Extracorporeal membrane oxygenation for the treatment of ARDS in Covid-19 and influenza patients: Does etiology matter?

DOI: 10.1177/03913988221092041

Year: 2022

Severe West Nile Virus Neuroinvasive Disease: Clinical Characteristics, Short- and Long-Term Outcomes

DOI: 10.3390/pathogens11010052

Year: 2022

Association of Nonalcoholic Fatty Liver Disease With COVID-19 Severity and Pulmonary Thrombosis: CovidFAT, a Prospective, Observational Cohort Study

DOI: 10.1093/ofid/ofac073

Year: 2022

Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection

DOI: 10.3390/antibiotics10070780

Year: 2021

Non-Alcoholic Fatty Liver Disease is Associated with an Increased Mortality in Adult Patients with Group B Streptococcus Invasive Disease

DOI: 10.37797/ig.40.4.2

Year: 2021

311. Impact of Non-alcoholic Fatty Liver Disease on Clinical Outcomes in Patients with COVID-19

DOI: 10.1093/ofid/ofab466.513

Year: 2021

Mid trimester amniotic fluid soluble receptor tunica interna endothelial cell kinase-2 levels and risk for preeclampsia.

DOI: 10.1016/j.preghy.2021.12.009

Year: 2021

The role of non-alcoholic fatty liver disease in bacterial infections and sepsis

DOI: 10.26800/lv-143-5-6-9

Year: 2021

Non-Alcoholic Fatty Liver Disease and Sepsis

DOI: 10.37797/ig.40.4.1

Year: 2021

Etiology and outcome of bacterial infections in patients with liver cirrhosis

DOI: 10.37797/ig.39.4.1

Year: 2020

Are There Any Concerns About Drug Resistance?

Are There Any Side Effects?

When Should You Seek Medical Attention?

What is the Prognosis for Children with Microcephaly?

Are condoms effective against all STIs?

Why are Serological Tests Important?

What vaccinations should be considered?

What are the Achievements of the RBM Partnership?

How is RT-PCR different from other diagnostic methods?

Why is Hygiene Important in Infectious Diseases?

Partnered Content Networks

Relevant Topics